| NCT Number | NCT06492655 |
| Lead Sponsor | Chong Kun Dang Pharmaceutical |
| Conditions | Type 2 Diabetes Mellitus |
| Enrollment | 28 participants |
| Start Date | 2024-07-04 |
| Primary Completion | 2024-08-01 (estimated) |
| Study Completion | 2024-08-08 (estimated) |
| Updated on ClinicalTrials.gov | 2024-07-10 |